This HTML5 document contains 178 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37638021
rdf:type
wikibase:Item
schema:description
wissenschaftlicher Artikel наукова стаття, опублікована в січні 2013 vedecký článok artigo científico articolo scientifico article scientifique научни чланак vědecký článek vetenskaplig artikel wetenschappelijk artikel artículu científicu espublizáu en 2013 scientific article published on January 2013 videnskabelig artikel bilimsel makale article científic مقالة علمية نشرت في يناير 2013
p:P577
wds:Q37638021-3E955C0A-8930-4C55-BDB6-E9F852F54063
wdt:P577
2013-01-01T00:00:00Z
p:P2860
wds:Q37638021-FA2B3FD3-FBB2-49CF-8001-59D9D734ADD8 wds:Q37638021-EEAA3070-F42B-485E-A210-139A82B54D3D wds:Q37638021-F4342C4D-012A-4B4F-8140-E66E31353BE7 wds:Q37638021-F72ADF34-3C73-4A7F-8455-DF679AE6E1BD wds:Q37638021-D74473E0-DD5D-4867-AA29-A12CA4586854 wds:Q37638021-DEE323E1-2623-4E76-B12C-E3E12D71E02B wds:Q37638021-DF37E063-25BD-41F9-ABBA-15672CF07F00 wds:Q37638021-06CA17C8-E00A-481F-9ECE-4DF6EE9F86AF wds:Q37638021-220B6255-E93E-4902-9301-A4DB47B98650 wds:Q37638021-2F91E68B-2A56-4C15-AE97-F37CBBD7AAAB wds:Q37638021-33227499-747B-4D0A-ACEF-1ECFE50C92F4 wds:Q37638021-3636DC9D-65E0-48A6-8467-F85293255A41 wds:Q37638021-17B95A4A-A971-4EB7-A066-0821CD964A38 wds:Q37638021-2143EA2A-D6AD-4EA6-A551-F139DCB9F731 wds:Q37638021-14B34D0A-E48A-4B1F-B4C7-6175EF8979AF wds:Q37638021-16AC0006-2CE7-4B0C-A09A-16BF73358649 wds:Q37638021-08173C50-09BA-444F-9057-5A47F22A0679 wds:Q37638021-0B4A6534-219D-49EB-8455-B93BC196733C wds:Q37638021-0E2C9426-DF7A-453B-82B2-FE8861314DAB wds:Q37638021-6322F7E7-6321-4377-B9BB-8CB0CEF78608 wds:Q37638021-4BE75061-2BCF-4183-9C61-2D212612228A wds:Q37638021-56B5AB12-6403-4AE0-8E01-96D63B253700 wds:Q37638021-5D430E6B-A87F-48FF-9A65-2A6AD38DE75C wds:Q37638021-5ED0FBA4-EAE0-4D2F-B8E6-646CBC5380C8 wds:Q37638021-42EB33F9-A227-46F4-9F53-F62837BBF739 wds:Q37638021-48EC798E-A92D-49C7-91E7-1D07D94BE44C wds:Q37638021-3F93D515-F606-43BE-8477-8582D8616EB4 wds:Q37638021-975C44D8-AA30-4144-9CCE-63690F7DE6A4 wds:Q37638021-A1B0B207-E5FD-40D4-BCCB-48BA3AF722B3 wds:Q37638021-833DA0B0-4A21-4943-928B-76D9EE7ACAD6 wds:Q37638021-86EAFDCB-CEE4-45E2-AA57-DF7D2E707CCE wds:Q37638021-86FF75F4-F408-406B-A528-82D7E90C09B0 wds:Q37638021-94BC0698-C135-491F-9191-9E3BCD06D5BB wds:Q37638021-7E10DE1A-B211-440E-826D-44FBE78B17DB wds:Q37638021-7FAFA810-BB83-4AF4-AEDE-B972CD3BD7CE wds:Q37638021-6F93B3BA-DD9B-49BC-9E44-3277FA0E59AF wds:Q37638021-7224B2EB-FD06-4914-9631-370A5F2A3783 wds:Q37638021-D2747355-197B-4A1F-ADB8-2AB833772F02 wds:Q37638021-C6E2C117-2928-453F-8855-0372EEDC96BD wds:Q37638021-CBB85ADD-DC1E-4108-96D7-478ABC08E439 wds:Q37638021-CC12611D-ADD7-4E93-958C-2FDD902DBCD9 wds:Q37638021-B378CCA5-AB61-4152-A143-D6DB97E44793 wds:Q37638021-BEAF63B0-CF68-4885-B4B1-FFCFD7D99284 wds:Q37638021-C3724E1C-007A-44D0-9A52-8DA034A9ABEA wds:Q37638021-AEB8CB56-04F7-4F24-B670-0202CC38A79E wds:Q37638021-AEE0B6DE-AD54-4EF3-929C-88CB2049D3CE wds:Q37638021-B0A8C9DE-ABC1-48B6-A8AE-5DE34854850D
wdt:P2860
wd:Q36033312 wd:Q77725517 wd:Q28645742 wd:Q40855199 wd:Q46981475 wd:Q37329862 wd:Q29619455 wd:Q44947217 wd:Q28215266 wd:Q73259342 wd:Q27860586 wd:Q30440717 wd:Q24303972 wd:Q22254443 wd:Q53246749 wd:Q40591759 wd:Q36206818 wd:Q34168724 wd:Q34293584 wd:Q36677501 wd:Q34623795 wd:Q24310473 wd:Q36969724 wd:Q43545365 wd:Q35847805 wd:Q21246014 wd:Q22009126 wd:Q84513033 wd:Q51584233 wd:Q34530992 wd:Q62647634 wd:Q24681394 wd:Q28266078 wd:Q34124356 wd:Q54384796 wd:Q56959573 wd:Q28594797 wd:Q35121609 wd:Q74605768 wd:Q24318508 wd:Q29547625 wd:Q46398274 wd:Q24302137 wd:Q51999490 wd:Q24301080 wd:Q42151770 wd:Q34451553
p:P2093
wds:Q37638021-E18F93B7-0030-4A37-A528-36EFC6C2F7F8 wds:Q37638021-D57B1FB1-1F7C-4B8E-ADF7-BDB63A619749 wds:Q37638021-CF5865B0-7C7C-4851-B8CF-75AC519EF6F7 wds:Q37638021-AB648288-4D71-4172-BA3B-EF3E62726718 wds:Q37638021-B1E382E4-D31B-4164-B1EA-1CA25439A29A wds:Q37638021-A89817BA-E664-48BD-9AC4-B866E52D6433 wds:Q37638021-798615ED-2D85-4FB2-9D1F-6618E08ABE44 wds:Q37638021-644FE07E-637E-4891-A06D-F6EF0C5F492D wds:Q37638021-40282E2E-05FB-4CC5-A3B8-E0B9E907851A wds:Q37638021-388863F5-54CD-4C83-A2F9-CC2463D0F9A7 wds:Q37638021-1EFC21E6-5F3A-4073-981A-650F256FB5D4 wds:Q37638021-11DBBBDC-34D7-458B-A245-DE929B5E0D8D wds:Q37638021-1623E6F4-AD42-4A1F-89D9-DF39E3BB8CC3 wds:Q37638021-13643942-A3C5-4F5C-9105-F5E57CBAC06B
wdt:P2093
Mohamed E Salama Lei Shi Guido Tricot He Wang Jiliang Xia Fenghuang Zhan Wen Zhou Zhaoyang Zeng Tiehua Chen Ye Yang Shashirekha Shetty Rodney Miles Hongwei Xu Wei Xiong
rdfs:label
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers
skos:prefLabel
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers
schema:name
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers
p:P50
wds:Q37638021-82D46FD7-BE9A-49C0-ADF3-5DA377A40388 wds:Q37638021-6144729B-DF47-4107-894D-660FF0A537AC
wdt:P50
wd:Q30507011 wd:Q66381375
p:P1476
wds:Q37638021-49E8BD00-A40A-417D-BE7F-FC6EDEE97383
wdt:P1476
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers
p:P304
wds:Q37638021-82DC2AFC-F89C-4995-AE4D-9BC43F1FBD36
wdt:P304
48-62
p:P31
wds:Q37638021-FAB86304-92BC-4E71-B287-9A08785312F1
wdt:P31
wd:Q13442814
p:P698
wds:Q37638021-CD639F8F-DE14-4DF3-8D28-910591F2F17C
wdtn:P698
n10:23328480
wdt:P698
23328480
p:P1433
wds:Q37638021-4B4DC1ED-4199-4853-ADF3-93C0256A1DD8
wdt:P1433
wd:Q280018
p:P433
wds:Q37638021-A43C28CA-CFB1-43C9-8064-62E22FDBE9D9
p:P478
wds:Q37638021-EA487389-54AC-4E8B-8226-766CC03EA954
wdt:P433
1
wdt:P478
23
p:P356
wds:Q37638021-1C0D2189-5C1B-4E1B-B0D2-BAA4D4562812
wdtn:P356
n11:J.CCR.2012.12.001
wdt:P356
10.1016/J.CCR.2012.12.001
p:P5875
wds:Q37638021-C5E6DF06-F297-475C-AB0C-278803C8FF17
wdt:P5875
234160894
p:P4510
wds:Q37638021-63D905FD-6A20-4F23-AAFE-A1D58CE3CB75
wdt:P4510
wd:Q1659584
p:P932
wds:Q37638021-7830FC40-441E-45A0-A24A-945D0B5DCC07
wdt:P932
3954609